BOOTHBAY FUND MANAGEMENT, LLC - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 55 filers reported holding PROQR THRAPEUTICS N V in Q1 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q3 2023$124,469
-19.8%
95,7450.0%0.00%0.0%
Q2 2023$155,107
-23.9%
95,7450.0%0.00%
-25.0%
Q1 2023$203,937
-39.0%
95,745
+6.0%
0.00%
-50.0%
Q4 2022$334,055
+119.8%
90,285
+396.3%
0.01%
+100.0%
Q3 2021$152,000
-41.3%
18,191
-52.6%
0.00%
-50.0%
Q2 2021$259,000
-27.5%
38,408
+6.5%
0.01%
-74.2%
Q4 2019$357,00036,0510.03%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q1 2023
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,237,400$5,197,0001.55%
Prosight Management, LP 255,000$1,071,0000.50%
RTW INVESTMENTS, LP 5,009,768$21,041,0000.35%
Kerrisdale Advisers, LLC 453,182$1,903,0000.15%
Artal Group S.A. 1,196,218$5,024,0000.11%
COWEN AND COMPANY, LLC 285,696$1,200,0000.11%
Golden Green, Inc. 16,999$71,0000.07%
APOGEM CAPITAL LLC 15,855$67,0000.04%
ADAGE CAPITAL PARTNERS GP, L.L.C. 4,550,062$19,110,0000.04%
ALTRINSIC GLOBAL ADVISORS LLC 241,360$1,014,0000.03%
View complete list of PROQR THRAPEUTICS N V shareholders